g
ene
transfer
airway
alveolar
epitheli
cell
vivo
continu
offer
hope
therapeut
approach
genet
diseas
cystic
fibrosi
cf
pharmaceut
deliveri
techniqu
acut
acquir
lung
injuri
power
research
tool
howev
success
sustain
gene
express
epithelium
often
limit
factor
associ
effect
vector
deliveri
particularli
injur
diseas
lung
innat
inflammatori
immun
respons
vector
longev
gene
express
one
hypothet
mean
overcom
last
limit
would
target
endogen
progenitor
cell
lung
cell
would
subsequ
provid
sustain
widespread
gene
express
daughter
cell
aris
progenitorcel
popul
howev
specif
target
endogen
airway
progenitor
cell
previous
describ
context
time
import
work
liu
colleagu
issu
molecular
therapi
elegantli
demonstr
recombin
adenoassoci
viru
aav
vector
notabl
seem
preferenti
transduc
progenitor
cell
lower
airway
mice
excit
new
find
provid
import
platform
specif
target
airway
progenitor
cell
rais
hope
duplic
human
approach
may
someday
use
clinic
gene
therapi
attempt
cf
lung
diseas
endogen
tissu
stem
cell
undifferenti
cell
identifi
nearli
tissu
includ
lung
thought
contribut
tissu
mainten
repair
rare
highli
special
cell
often
local
special
nich
within
tissu
selfrenew
although
usual
cycl
infrequ
also
give
rise
daughter
cell
known
progenitor
cell
transitamplifi
cell
stem
progenitor
cell
may
give
rise
special
differenti
cell
organ
focu
lung
predominantli
epitheli
progenitor
cell
increas
evid
indic
potenti
exist
vascular
mesenchym
progenitor
cell
popul
well
moreov
lung
complex
organ
sever
airway
epitheli
stem
progenitorcel
hierarchi
identifi
along
tracheobronchi
tree
mous
model
figur
trachea
larg
airway
subpopul
basal
epitheli
cell
express
cytokeratin
implic
also
identifi
possibl
marker
human
fetal
airway
progenitor
cell
lower
airway
mice
clara
cell
exhibit
characterist
transitamplifi
cell
follow
injuri
differenti
ciliat
airway
epitheli
cell
howev
unlik
transitamplifi
cell
tissu
higher
rate
epitheli
turnov
intestin
clara
cell
show
low
prolif
frequenc
steadi
state
broadli
distribut
throughout
bronchio
lar
epithelium
contribut
special
tissu
function
distal
airway
toxin
ie
naphthalen
resist
variant
clara
cell
identifi
stem
cell
function
term
bronchiolar
stem
cell
naphthaleneresist
cell
also
locat
within
discret
micro
environ
within
bronchiol
includ
neuro
epitheli
bodi
bronchioalveolar
duct
junction
badj
anoth
popul
naphthaleneresist
cell
stain
clara
cell
secretori
protein
ccsp
prosurfact
protein
c
term
bronchioalveolar
stem
cell
basc
also
describ
badj
mice
possibl
toxinresist
clara
cell
basc
cell
may
repres
differ
interpret
cell
popul
highlight
need
rigor
method
lineag
trace
underscor
import
vivo
microenviron
cell
behavior
recent
anoth
popul
put
progenitor
cell
express
ccsp
stem
cell
antigen
stagespecif
embryon
antigen
embryon
stem
cell
marker
identifi
neonat
mice
cell
abl
form
epith
elial
coloni
diff
erenti
type
type
alveolar
epitheli
cell
interestingli
cell
suscept
infect
sever
acut
respiratori
syndrom
sar
viru
rais
possibl
endo
genou
lung
progenitor
cell
may
specif
diseas
target
possibl
remain
endogen
stem
progenitor
popul
exist
much
room
addit
inform
regulatori
mechan
pathway
elucid
epitheli
progenitor
cell
popul
review
ref
human
correl
endogen
airway
progenitor
popul
describ
mice
less
well
understood
defin
human
airway
progenitor
popul
critic
step
focu
intens
research
activ
endogen
progenitor
cell
may
also
attract
candid
target
gene
transfer
vector
provid
sustain
express
use
adult
transgen
report
mice
liu
colleagu
demonstr
airwaybas
administr
recombin
cre
commentari
vector
preferenti
transduc
type
alveolar
epitheli
cell
cell
conduct
larger
airway
notabl
number
conduct
airway
cell
predominantli
clara
cell
overal
amount
activ
lung
homogen
steadili
increas
period
reach
respect
cre
cre
total
activ
measur
posit
control
report
micedespit
absenc
detect
cre
clara
cell
specul
might
result
part
raavmedi
transduct
airway
progenitor
cell
investig
administ
naphthalen
mice
select
deplet
clara
cell
leav
place
toxinresist
variant
clara
cell
might
serv
precursor
administr
either
cre
cre
along
bromodeoxyuridin
brdu
identifi
laczposit
laczneg
labelretain
cell
bronchiolar
airway
badj
type
alveolar
epitheli
cell
import
point
laczposit
labelretain
cell
bronchiolar
airway
found
whether
vector
given
naphthalen
brdu
administr
immunostain
demonstr
subset
lacz
posit
labelretain
cell
bronchiolar
airway
badj
stain
ccsp
infrequ
cell
associ
larg
transgeneexpress
patch
cell
consist
clonal
expans
raavtransduc
stemprogenitor
cell
regener
airway
epithelium
inde
analysi
mice
month
infect
demonstr
larger
laczposit
cell
cluster
suggest
clonal
expans
moreov
primari
cultur
epitheli
cell
obtain
extralobar
bronchi
creand
cretransduc
mice
demonstr
sixto
sevenfold
increas
colonyform
effici
cultur
airliquid
interfac
result
suggest
select
transduc
airway
epitheli
cell
vivo
higher
prolif
capac
notabl
compar
result
found
vector
excit
find
support
possibl
select
preferenti
transduc
stemprogenitor
cell
popul
lung
although
much
investig
necessari
provid
new
potenti
therapeut
approach
diseas
affect
airway
alveolar
epithelium
exampl
airway
epithelium
cf
patient
contain
primit
cuboid
cell
express
primit
cell
marker
includ
thyroid
transcript
factor
cytokeratin
ref
cf
transmembran
conduct
regul
knockout
mice
also
contain
fewer
pulmonari
neuroendocrin
cell
embryon
develop
increas
number
cell
postnat
suggest
endogen
progenitor
cell
pathway
cf
lung
may
alter
potenti
amen
select
transduct
raav
vector
whether
lung
diseas
prove
amen
approach
remain
determin
furthermor
despit
grow
understand
ident
role
airway
endogen
lung
stemprogenitor
cell
mice
littl
compar
inform
avail
human
lung
nonetheless
union
gene
cell
therapi
hold
promis
lung
diseas
deliveri
allogen
msc
report
rel
recent
difficult
verifi
safeti
allogen
host
use
cellular
vector
gene
deliveri
thu
safeti
use
msc
therapeut
gene
transfer
remain
establish
campeau
et
al
report
unexpect
phenotyp
immunolog
effect
follow
deliveri
allogen
msc
engin
express
epo
mice
differ
haplotyp
balbc
figur
msc
mice
engin
express
epo
use
retrovir
system
engin
cell
inject
subcutan
healthi
syngen
mice
allogen
balbc
mice
case
transient
increas
hematocrit
although
baselin
level
epo
maintain
follow
cell
transfer
syngen
transplant
hematocrit
level
soon
decreas
baselin
level
allogen
transplant
allogen
mice
show
rapid
increas
antibodi
epo
antiepo
whose
level
sustain
least
week
contrast
gradual
increas
antiepo
level
syngen
anim
week
signific
differ
hematocrit
level
two
strain
mice
could
explain
differ
antiepo
level
author
explor
paradox
determin
whether
differ
neutral
abil
antiepo
two
strain
mice
use
eporespons
cell
line
author
compar
neutral
properti
antiepo
sera
strain
treat
mice
although
antiepo
allogen
sera
abl
neutral
epo
sera
syngen
sera
show
partial
neutral
izat
suggest
differ
avid
antibodi
understand
mechan
epo
express
induc
antiepo
allogen
mice
author
analyz
msc
cytokin
secret
major
upregul
cytokin
epoengin
msc
cc
motif
chemokin
show
evid
involv
antiepo
respons
suggest
mechan
andor
involv
cytokin
show
promis
gene
deliveri
treat
variou
diseas
anemia
stroke
well
oncolog
neural
disord
issu
molecular
therapi
campeau
et
al
report
experiment
model
compar
respons
allogen
syngen
host
transfer
erythropoietin
epo
express
msc
studi
base
premis
epo
could
deliv
use
genet
modifi
msc
treat
anemia
myocardi
infarct
treatment
anemia
expand
autolog
msc
seem
plausibl
chronic
natur
anemia
compat
time
need
expand
bone
msc
suffici
number
howev
case
acut
disord
myocardi
infarct
stroke
gene
deliveri
intervent
would
immedi
therebi
elimin
autolog
genemodifi
msc
option
msc
report
suppress
allogen
respons
particular
graftversushost
diseas
offtheshelf
sourc
cell
propos
treat
variou
clinic
disord
requir
intervent
earli
time
point
allogen
msc
alreadi
evalu
clinic
treat
graftversushost
respons
autoimmun
disord
treatment
base
immunosuppress
properti
msc
msc
thirdparti
cell
allogen
hematopoiet
stem
cell
transplant
set
function
immunouppress
cell
similar
immunosuppress
would
relev
autolog
transplant
reject
would
problem
despit
promis
msc
thirdparti
cell
type
applic
differ
deliveri
msc
allogen
host
